1. Home
  2. WBX vs VYGR Comparison

WBX vs VYGR Comparison

Compare WBX & VYGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wallbox N.V.

WBX

Wallbox N.V.

HOLD

Current Price

$3.00

Market Cap

118.0M

ML Signal

HOLD

Logo Voyager Therapeutics Inc.

VYGR

Voyager Therapeutics Inc.

HOLD

Current Price

$4.08

Market Cap

232.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WBX
VYGR
Founded
2015
2013
Country
Spain
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
118.0M
232.4M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
WBX
VYGR
Price
$3.00
$4.08
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$9.00
$17.00
AVG Volume (30 Days)
28.1K
467.1K
Earning Date
02-26-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$174,593,453.00
$31,316,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$33.37
$71.78
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.85
$2.65
52 Week High
$14.40
$6.37

Technical Indicators

Market Signals
Indicator
WBX
VYGR
Relative Strength Index (RSI) 36.00 41.78
Support Level $2.88 $4.24
Resistance Level $3.36 $4.58
Average True Range (ATR) 0.23 0.23
MACD 0.03 -0.00
Stochastic Oscillator 17.31 34.95

Price Performance

Historical Comparison
WBX
VYGR

About WBX Wallbox N.V.

Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.

About VYGR Voyager Therapeutics Inc.

Voyager Therapeutics Inc is a gene therapy company focused on developing life-changing treatments for patients suffering from severe neurological diseases. It focuses on neurological diseases where an adeno-associated virus, or AAV, gene therapy approach that either increases or decreases the production of a specific protein can slow or reduce the symptoms experienced by patients, and therefore have a clinically meaningful impact. The company's gene therapy platform TRACER enables to engineer, optimize, manufacture and deliver AAV-based gene therapies that have the potential to provide durable efficacy following a single administration. Its pipeline of programs include, Anti-tau Antibody (VY-TAU01), SOD1 Silencing Gene Therapy (siRNA), FXN Gene Therapy among others.

Share on Social Networks: